nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—DRD5—Dopamine receptors—DRD4—conduct disorder	0.107	0.107	CbGpPWpGaD
Fenoldopam—DRD1—Dopamine receptors—DRD4—conduct disorder	0.0708	0.0708	CbGpPWpGaD
Fenoldopam—DRD2—Dopamine receptors—DRD4—conduct disorder	0.0535	0.0535	CbGpPWpGaD
Fenoldopam—DRD5—Monoamine GPCRs—DRD4—conduct disorder	0.0236	0.0236	CbGpPWpGaD
Fenoldopam—DRD5—Amine ligand-binding receptors—DRD4—conduct disorder	0.0198	0.0198	CbGpPWpGaD
Fenoldopam—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.017	0.017	CbGpPWpGaD
Fenoldopam—DRD1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.016	0.016	CbGpPWpGaD
Fenoldopam—DRD1—Monoamine GPCRs—DRD4—conduct disorder	0.0157	0.0157	CbGpPWpGaD
Fenoldopam—ADRA1D—Monoamine GPCRs—DRD4—conduct disorder	0.0154	0.0154	CbGpPWpGaD
Fenoldopam—DRD5—Monoamine GPCRs—HTR2A—conduct disorder	0.0154	0.0154	CbGpPWpGaD
Fenoldopam—DRD5—G alpha (s) signalling events—CGA—conduct disorder	0.0146	0.0146	CbGpPWpGaD
Fenoldopam—ADRA2B—Monoamine GPCRs—DRD4—conduct disorder	0.0139	0.0139	CbGpPWpGaD
Fenoldopam—DRD1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0132	0.0132	CbGpPWpGaD
Fenoldopam—ADRA2C—Monoamine GPCRs—DRD4—conduct disorder	0.013	0.013	CbGpPWpGaD
Fenoldopam—ADRA1D—Amine ligand-binding receptors—DRD4—conduct disorder	0.013	0.013	CbGpPWpGaD
Fenoldopam—DRD5—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0129	0.0129	CbGpPWpGaD
Fenoldopam—ADRA1B—Monoamine GPCRs—DRD4—conduct disorder	0.0128	0.0128	CbGpPWpGaD
Fenoldopam—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0121	0.0121	CbGpPWpGaD
Fenoldopam—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.0118	0.0118	CbGpPWpGaD
Fenoldopam—ADRA2B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0117	0.0117	CbGpPWpGaD
Fenoldopam—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.0114	0.0114	CbGpPWpGaD
Fenoldopam—ADRA2C—Amine ligand-binding receptors—DRD4—conduct disorder	0.0109	0.0109	CbGpPWpGaD
Fenoldopam—ADRA1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0108	0.0108	CbGpPWpGaD
Fenoldopam—ADRA2A—Monoamine GPCRs—DRD4—conduct disorder	0.0106	0.0106	CbGpPWpGaD
Fenoldopam—DRD1—Monoamine GPCRs—HTR2A—conduct disorder	0.0102	0.0102	CbGpPWpGaD
Fenoldopam—ADRA1D—Monoamine GPCRs—HTR2A—conduct disorder	0.0101	0.0101	CbGpPWpGaD
Fenoldopam—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00993	0.00993	CbGpPWpGaD
Fenoldopam—DRD1—G alpha (s) signalling events—CGA—conduct disorder	0.00969	0.00969	CbGpPWpGaD
Fenoldopam—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00957	0.00957	CbGpPWpGaD
Fenoldopam—ADRA2B—Monoamine GPCRs—HTR2A—conduct disorder	0.0091	0.0091	CbGpPWpGaD
Fenoldopam—ADRA2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00889	0.00889	CbGpPWpGaD
Fenoldopam—DRD1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00859	0.00859	CbGpPWpGaD
Fenoldopam—ADRA2C—Monoamine GPCRs—HTR2A—conduct disorder	0.0085	0.0085	CbGpPWpGaD
Fenoldopam—ADRA1D—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00847	0.00847	CbGpPWpGaD
Fenoldopam—ADRA1B—Monoamine GPCRs—HTR2A—conduct disorder	0.00836	0.00836	CbGpPWpGaD
Fenoldopam—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.00771	0.00771	CbGpPWpGaD
Fenoldopam—ADRA2B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00765	0.00765	CbGpPWpGaD
Fenoldopam—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.00743	0.00743	CbGpPWpGaD
Fenoldopam—ADRA2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00714	0.00714	CbGpPWpGaD
Fenoldopam—ADRA1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00703	0.00703	CbGpPWpGaD
Fenoldopam—DRD5—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00696	0.00696	CbGpPWpGaD
Fenoldopam—ADRA2A—Monoamine GPCRs—HTR2A—conduct disorder	0.0069	0.0069	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Other—DRD4—conduct disorder	0.00686	0.00686	CbGpPWpGaD
Fenoldopam—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00648	0.00648	CbGpPWpGaD
Fenoldopam—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00625	0.00625	CbGpPWpGaD
Fenoldopam—ADRA2A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0058	0.0058	CbGpPWpGaD
Fenoldopam—DRD5—GPCR ligand binding—CGA—conduct disorder	0.0053	0.0053	CbGpPWpGaD
Fenoldopam—DRD1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00462	0.00462	CbGpPWpGaD
Fenoldopam—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00456	0.00456	CbGpPWpGaD
Fenoldopam—DRD5—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00455	0.00455	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Other—HTR2A—conduct disorder	0.00448	0.00448	CbGpPWpGaD
Fenoldopam—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00412	0.00412	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—SLC6A4—conduct disorder	0.00392	0.00392	CbGpPWpGaD
Fenoldopam—DRD5—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0039	0.0039	CbGpPWpGaD
Fenoldopam—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00385	0.00385	CbGpPWpGaD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00378	0.00378	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—DRD4—conduct disorder	0.00369	0.00369	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—CGA—conduct disorder	0.00352	0.00352	CbGpPWpGaD
Fenoldopam—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00349	0.00349	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—CGA—conduct disorder	0.00347	0.00347	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00336	0.00336	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—CGA—conduct disorder	0.00314	0.00314	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00312	0.00312	CbGpPWpGaD
Fenoldopam—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00302	0.00302	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—CGA—conduct disorder	0.00299	0.00299	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00298	0.00298	CbGpPWpGaD
Fenoldopam—DRD5—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00297	0.00297	CbGpPWpGaD
Fenoldopam—DRD5—GPCR ligand binding—DRD4—conduct disorder	0.00297	0.00297	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.00296	0.00296	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—CGA—conduct disorder	0.00293	0.00293	CbGpPWpGaD
Fenoldopam—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.0029	0.0029	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.00288	0.00288	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.00279	0.00279	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—CGA—conduct disorder	0.00272	0.00272	CbGpPWpGaD
Fenoldopam—ADRA2C—G alpha (i) signalling events—DRD4—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00269	0.00269	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—CGA—conduct disorder	0.00266	0.00266	CbGpPWpGaD
Fenoldopam—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00259	0.00259	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.00256	0.00256	CbGpPWpGaD
Fenoldopam—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00255	0.00255	CbGpPWpGaD
Fenoldopam—DRD5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00254	0.00254	CbGpPWpGaD
Fenoldopam—ADRA1D—G alpha (q) signalling events—HTR2A—conduct disorder	0.00252	0.00252	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00251	0.00251	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00247	0.00247	CbGpPWpGaD
Fenoldopam—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.00246	0.00246	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.00238	0.00238	CbGpPWpGaD
Fenoldopam—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00231	0.00231	CbGpPWpGaD
Fenoldopam—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00228	0.00228	CbGpPWpGaD
Fenoldopam—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00225	0.00225	CbGpPWpGaD
Fenoldopam—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.0022	0.0022	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0022	0.0022	CbGpPWpGaD
Fenoldopam—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00215	0.00215	CbGpPWpGaD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00212	0.00212	CbGpPWpGaD
Fenoldopam—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00209	0.00209	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00204	0.00204	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.00199	0.00199	CbGpPWpGaD
Fenoldopam—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00197	0.00197	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.00197	0.00197	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.00196	0.00196	CbGpPWpGaD
Fenoldopam—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00195	0.00195	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Fenoldopam—DRD5—GPCR ligand binding—HTR2A—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00188	0.00188	CbGpPWpGaD
Fenoldopam—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00187	0.00187	CbGpPWpGaD
Fenoldopam—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.00185	0.00185	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—CGA—conduct disorder	0.00181	0.00181	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.00178	0.00178	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.00177	0.00177	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00176	0.00176	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.00176	0.00176	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00175	0.00175	CbGpPWpGaD
Fenoldopam—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00169	0.00169	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—DRD4—conduct disorder	0.00168	0.00168	CbGpPWpGaD
Fenoldopam—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00167	0.00167	CbGpPWpGaD
Fenoldopam—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00166	0.00166	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.00165	0.00165	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.00163	0.00163	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CGA—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—DRD4—conduct disorder	0.00152	0.00152	CbGpPWpGaD
Fenoldopam—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CGA—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Fenoldopam—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00149	0.00149	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.00149	0.00149	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.00148	0.00148	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.00145	0.00145	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Fenoldopam—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00141	0.00141	CbGpPWpGaD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00138	0.00138	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CGA—conduct disorder	0.00136	0.00136	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.00134	0.00134	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00133	0.00133	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.00133	0.00133	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.00131	0.00131	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—WASF1—conduct disorder	0.00129	0.00129	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—HTR2A—conduct disorder	0.00129	0.00129	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—EP300—conduct disorder	0.00128	0.00128	CbGpPWpGaD
Fenoldopam—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00127	0.00127	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	0.00127	0.00127	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.00122	0.00122	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.00115	0.00115	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00114	0.00114	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—DRD4—conduct disorder	0.00111	0.00111	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	0.0011	0.0011	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	0.00107	0.00107	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CGA—conduct disorder	0.00107	0.00107	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CGA—conduct disorder	0.00106	0.00106	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.00105	0.00105	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CGA—conduct disorder	0.00105	0.00105	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—DRD4—conduct disorder	0.00101	0.00101	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	0.000998	0.000998	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—HTR2A—conduct disorder	0.000993	0.000993	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	0.000992	0.000992	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000971	0.000971	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.000963	0.000963	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CGA—conduct disorder	0.00095	0.00095	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.000935	0.000935	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	0.000927	0.000927	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.000912	0.000912	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	0.000901	0.000901	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—DRD4—conduct disorder	0.000899	0.000899	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CGA—conduct disorder	0.000888	0.000888	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.000874	0.000874	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.000869	0.000869	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CGA—conduct disorder	0.000862	0.000862	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—WASF1—conduct disorder	0.000855	0.000855	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—WASF1—conduct disorder	0.000844	0.000844	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	0.000842	0.000842	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.000841	0.000841	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.000828	0.000828	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.00081	0.00081	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CGA—conduct disorder	0.000806	0.000806	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.000776	0.000776	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—DRD4—conduct disorder	0.000764	0.000764	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—WASF1—conduct disorder	0.000762	0.000762	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	0.000753	0.000753	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.000736	0.000736	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	0.000727	0.000727	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CGA—conduct disorder	0.000721	0.000721	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	0.000717	0.000717	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—WASF1—conduct disorder	0.000712	0.000712	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—WASF1—conduct disorder	0.0007	0.0007	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	0.000684	0.000684	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—HTR2A—conduct disorder	0.00066	0.00066	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	0.000651	0.000651	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	0.000647	0.000647	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—WASF1—conduct disorder	0.000646	0.000646	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.000622	0.000622	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	0.000605	0.000605	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—DRD4—conduct disorder	0.000598	0.000598	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	0.000595	0.000595	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—DRD4—conduct disorder	0.00059	0.00059	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	0.000588	0.000588	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—HTR2A—conduct disorder	0.000587	0.000587	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—WASF1—conduct disorder	0.000578	0.000578	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	0.000549	0.000549	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	0.000549	0.000549	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—EP300—conduct disorder	0.000543	0.000543	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	0.00054	0.00054	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—DRD4—conduct disorder	0.000532	0.000532	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.000529	0.000529	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—EP300—conduct disorder	0.000507	0.000507	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—HTR2A—conduct disorder	0.000498	0.000498	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—DRD4—conduct disorder	0.000497	0.000497	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	0.000491	0.000491	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—DRD4—conduct disorder	0.000489	0.000489	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.00048	0.00048	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—COMT—conduct disorder	0.000479	0.000479	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—MAOA—conduct disorder	0.000476	0.000476	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—DRD4—conduct disorder	0.000451	0.000451	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	0.000446	0.000446	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.000435	0.000435	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—EP300—conduct disorder	0.000412	0.000412	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DRD4—conduct disorder	0.000404	0.000404	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HTR2A—conduct disorder	0.00039	0.00039	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—COMT—conduct disorder	0.000389	0.000389	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—MAOA—conduct disorder	0.000387	0.000387	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	0.000385	0.000385	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	0.000347	0.000347	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	0.000324	0.000324	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	0.000319	0.000319	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—EP300—conduct disorder	0.000311	0.000311	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HTR2A—conduct disorder	0.000294	0.000294	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.000284	0.000284	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	0.000263	0.000263	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EP300—conduct disorder	0.000207	0.000207	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—EP300—conduct disorder	0.000206	0.000206	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EP300—conduct disorder	0.000204	0.000204	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EP300—conduct disorder	0.000184	0.000184	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EP300—conduct disorder	0.000172	0.000172	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EP300—conduct disorder	0.000169	0.000169	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—EP300—conduct disorder	0.000167	0.000167	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EP300—conduct disorder	0.000156	0.000156	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EP300—conduct disorder	0.00015	0.00015	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EP300—conduct disorder	0.00014	0.00014	CbGpPWpGaD
